-
公开(公告)号:DK0896537T3
公开(公告)日:2000-03-06
申请号:DK97907081
申请日:1997-03-07
Applicant: HOECHST AG , AVENTIS PHARMA GMBH
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/275 , A61K31/42
-
公开(公告)号:ES2137055T3
公开(公告)日:1999-12-01
申请号:ES97907081
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:HU9902130A2
公开(公告)日:1999-11-29
申请号:HU9902130
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:BR9708108A
公开(公告)日:1999-07-27
申请号:BR9708108
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:PL328998A1
公开(公告)日:1999-03-01
申请号:PL32899897
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:NO984343L
公开(公告)日:1998-09-18
申请号:NO984343
申请日:1998-09-18
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: A solid composition comprising 5-methyl-4'-trifluoromethyl-4-isoxazole carboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, suitable for treatment of immunological and cancerous diseases.
-
公开(公告)号:CA2249348A1
公开(公告)日:1997-09-25
申请号:CA2249348
申请日:1997-03-07
Applicant: HOECHST AG
Inventor: THEN JOHANN , BARTLETT ROBERT
IPC: A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: Described is a solid preparation, containing 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, which is suitable for use in the treatment of immunological conditions.
-
公开(公告)号:AU630261B2
公开(公告)日:1992-10-22
申请号:AU6802490
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , SCHLEYERBACH RUDOLF , BARTLETT ROBERT , WEITHMANN KLAUS-ULRICH
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:ZA9010067B
公开(公告)日:1991-09-25
申请号:ZA9010067
申请日:1990-12-14
Applicant: HOECHST AG
Inventor: THORWART WERNER , WERNER THORWART , SCHLEYERBACH RUDOLF , RUDOLF SCHLEYERBACH , BARTLETT ROBERT , ROBERT BARTLETT , WEITHMANN KLAUS ULRICH , KLAUS ULRICH WEITHMANN
IPC: A61K31/425 , A61K31/426 , A61P29/00 , A61P37/00 , C07D277/24 , C07D277/26 , C07D277/28 , C07D277/30 , C07D417/06 , C07D417/12 , C07D
Abstract: Novel substituted thiazoles of the formula I (I) in which R1 is a saturated or unsaturated, straight-chain or branched C1-C5-alkyl group, R2 is a hydrogen atom or an alkyl radical having 1 to 3 carbon atoms, A is an intermediate chain of the formula -(CH2)n-Y-CR3R4-; -CH=CR3-(CH2)m- or -CH=N-O-(CH2)n- where Y is a single bond, an oxygen or sulfur atom or a carbonyl group, R3 and R4 are identical or different and are a hydrogen atom or an alkyl radical having up to two carbon atoms, m is a number from 0 to 3 and n is a number from 1 to 4, and Z is a tetrazole or CN group, or a radical of the formula X is a hydroxyl group or a radical of the formula R5O- or R6R7N-, where R5 is a straight-chain or branched C1-C4-alkyl radical which is optionally substituted by hydroxyl, C1-C3-alkoxy or C1-C3-alkylamino, R6 and R7 are identical or different and are a hydrogen atom, a straight-chain or branched C1-C6-alkyl radicall or, for the case in which R6 is a hydrogen atom or a C1-C4-alkyl radical, R7 is a hydroxyl, a C1-C3-alkoxy or a tetrazol-5-yl group or X, together with the structural element -A-(C=O)-, is a radical of the formula II (II) where R8 is a hydrogen atom, a C1-C3-alkyl radical or a C1-C3-alkoxy radical, and physiologically tolerable salts of such compounds of the formula I in which X is a hydroxyl or hydroxyamino group, are prepared by various processes. They are preferably suitable for the treatment and prophylaxis of inflammatory diseases - in particular inflammatory rheumatic diseases.
-
公开(公告)号:BG102697A
公开(公告)日:1999-09-30
申请号:BG10269798
申请日:1998-08-17
Applicant: HOECHST AG
Inventor: BARTLETT ROBERT , THEN JOHANN
IPC: A61K31/167 , A61K31/00 , A61K31/275 , A61K31/42 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , C07D261/18
Abstract: The invention relates to solid combined preparationcontaining (4-trifluoromethyl)-anilide of5-methylisoxazole-4-carboxylic acid and amide ofN-(4-trifluoromethylphenyl)-2-cyan-3-hydroxycrotonic acid and issuitable for the treatment of immunological diseases.11 claims
-
-
-
-
-
-
-
-
-